Latest Diasorin News & Updates

See the latest news and media coverage for Diasorin. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Diasorin

Manufacturer of immunodiagnostic and molecular diagnostic systems

diasorin.com
Headquarters
Saluggia, Italy
Company type
Public company
Number of employees
2,500–5,000

Last updated

Latest news about Diasorin

In short: Diasorin approved its 2026-2030 industrial plan, secured several FDA clearances for molecular assays, and appointed a new CFO and division president.

Company announcements

Diasorin

Diasorin reports Q1 2026 financial results

Revenues reach €287 million (-3% at CER), adjusted EBITDA €90 million (31% margin). Confirms 2026 guidance of 5-6% revenue growth. Launches LIAISON NES in US.

Diasorin

Diasorin approves 2025 financial statements and €1.30 dividend

Shareholders' meeting approves remuneration policy, second section of remuneration report, and new 2026 stock option plan for executives and employees.

Unlock all announcements with a

Media coverage

Milano Finanza

MARKET DRIVER: Diasorin, DB goes to sell

Real-time financial news from MF Market Driver. Follow the market trends, stock exchange listings and the main national economy news and...

ANSA

Stock Exchange: Milan holds steady awaiting news from the Middle East, Diasorin surges (+7%)

Few cues on the stock markets of the Old Continent which, awaiting concrete news from the Middle East, nevertheless marked a positive day. (ANSA...

Unlock all articles with a

Never miss news about Diasorin

Track Diasorin and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Diasorin competitors & trending companies

Browse news for competitors to Diasorin and other trending companies.